Transplantation Immunology and Immunogenetics


End stage failure of organs the system is lacking ability to tell apart the existence of helpful and harmful foreign pathogens. System has developed effective mechanisms to fight foreign agents therefore these mechanisms area unit concerned in transplant rejection. Graft-versus-host diseases area unit common issues in allogeneic tissue transplantation. Rejection is associate adaptive reaction that comes through cellular immunity and conjointly by body substance immunity although the action is joined by elements of innate reaction i.e. soluble immune differing kinds of transplanted tissues tend to favour various balances of rejection mechanisms. Today, most recipients of transplants area unit maintained on immunological disorder medication. The side-effects of such antirejection medication, which might themselves be life threatening, embrace increased risk of infection, cancer, diabetes, and different conditions. In time, however, several patients develop a tolerance to the deep-seated organs, and a few will eventually be weaned off the medication.


  • Allogeneic tissue transplantation
  • Cellular immunity
  • Immunological disorder medication
  • Differing kinds of transplanted tissues

Related Conference of Transplantation Immunology and Immunogenetics

February 24-25, 2025

11th International Conference on Surgeons

Madrid, Spain
May 19-20, 2025

10th International Conference on Surgery and Anaesthesia

Zurich, Switzerland
June 25-26, 2025

5th World Congress on Surgery

London, UK
July 21-22, 2025

8th World Congress on Surgeons

Barcelona, Spain
November 19-20, 2025

16th European Conference on Surgery & Cosmetology

Barcelona, Spain

Transplantation Immunology and Immunogenetics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in